Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The induction of tumor cell lysis and immunogenic cell death via viral replication refers to a therapeutic strategy using oncolytic viruses. These viruses preferentially infect and replicate within cancer cells, causing cell lysis. The process leads to the release of tumor antigens, DAMPs, and PAMPs, which stimulate both innate and adaptive antitumor immune responses. This mechanism combines direct cytotoxicity with immunological tumor clearance and forms the basis for oncolytic virotherapy—a new class of immunotherapy drugs under investigation for cancer treatment.
Direct lysis of tumor cells by viral replication Release of viral progeny, pathogen-associated molecular patterns (PAMPs), and danger-associated molecular patterns (DAMPs) Induction of immunogenic cell death and subsequent antitumor immunity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Induction of tumor cell lysis and immunogenic cell death via viral replication.